Hemophilia A, Hemophilia B
Conditions
Brief summary
The purpose of this study is to validate the newly developed Hemophilia Functional Ability Scoring Tool (Hemo-FAST), which is a fast and simple scoring in haemophilia able to assess patient-reported functional mobility.
Detailed description
The purpose of this study is to validate the newly developed Hemophilia Functional Ability Scoring Tool (Hemo-FAST), which is a fast and simple scoring in haemophilia able to assess patient-reported functional mobility for adult haemophilia patients.
Interventions
Joint examination with Hemophilia Joint Health Score (HJHS)
Sponsors
Study design
Eligibility
Inclusion criteria
A patient must fulfil the following criteria in order to be included in the study: 1. Age ≥18 years. 2. Diagnosis of haemophilia A or B. 3. Capable of completing the study Patient-Reported Outcome (PRO) questionnaires in French. 4. Signed informed consent.
Exclusion criteria
The presence of any of the following criteria will exclude a patient from inclusion in the study: 1. Joint replacement within last 6 months. 2. Patients with a non-resolved joint or muscle bleeding event at the enrolment visit or ≤ 7 days prior to the enrolment visit. 3. Patients with comorbid illnesses such as juvenile arthritis, muscular dystrophy, neurologic illness/cognitive impairment, or other illnesses that may independently affect HJHS and Hemo-FAST scores and/or limit the ability of the patient to participate in the study as determined by the investigator.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Psychometric validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST). | Baseline | Statistical analysis to confirm the psychometric validation of the Hemo-FAST questionnaire |
Countries
France